Founder of ion-channel screening at Bristol-Myers Squibb, Dr. C. David Weaver, presents July 14th Pharmacy Research Series

HSC College of Pharmacy Research Seminar Series invites you to:

“How Heavy Metal Changed My Life: High-throughput Approaches for Development
of New Anti-Epileptic Medicines”
Presented by C. David Weaver, Ph.D.
Senior Vice President of Neuroscience and Pharmacology, Biohaven Pharmaceuticals
Associate Professor, Departments of Pharmacology and Chemistry
Associate Director, Vanderbilt Institute for Chemical Biology Vanderbilt University
Nashville, Tennessee

Friday, July 14, 2023
11:00 a.m. – 12:00 p.m.
IREB 250

Career Highlights:
• Founder of ion-channel screening at Bristol-Myers Squibb
• Inventor of the thallium flux assay
• Founder and Scientific Director of the Vanderbilt HTS facility
• More than 130 peer-reviewed publications and book chapters